The treatment of RPE cells with resveratrol, which increases SIRT1 activity, suppresses inflammatory cytokine-induced vascular endothelial growth factor (VEGF) secretion, which is involved in age-related macular degeneration (AMD) [8]. The gene discussed is SIRT1; the disease is age-related macular degeneration.